Use of Ceftazidime-Avibactam in a Late-Preterm Newborn with Multidrug-Resistant <i>Enterobacter hormaechei</i> Sepsis. [PDF]
Trizzino M +10 more
europepmc +1 more source
Antimicrobial activity of aztreonam/avibactam and molecular characterization of Enterobacterales not susceptible to ceftazidime/avibactam and/or meropenem/vaborbactam from US medical centres (2016-2024). [PDF]
Sader HS +5 more
europepmc +1 more source
The resistance mechanisms and risk factors of carbapenem-resistant Klebsiella pneumoniae to ceftazidime-avibactam. [PDF]
He X +7 more
europepmc +1 more source
Comparison of Ceftolozane-Tazobactam and Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant/Difficult-to-Treat Resistant Pseudomonas aeruginosa Infections: A Systematic Review and Meta-analysis. [PDF]
Gatti M, De Paola R, Giorgi B, Pea F.
europepmc +1 more source
Ceftazidime-Avibactam-Induced Neurotoxicity Manifesting as Seizure in an Older Adult: A Case Report. [PDF]
Li Z, Li C, Zhao P, Han Y, Lu N.
europepmc +1 more source
Disease severity modifies the ceftazidime-avibactam exposure-response relationship in critically ill patients: a retrospective study. [PDF]
Qian S, Xu D, Xu Y, Qi H, Liang P.
europepmc +1 more source
Emergence of ceftazidime-avibactam resistance mediated by KPC variants KPC-71 and KPC-78 in ST463 <i>Pseudomonas aeruginosa</i>. [PDF]
Yang F +12 more
europepmc +1 more source
Hope Against Resistance: In Vitro Activity of the Ceftazidime-Avibactam and Aztreonam Combination Against Colistin-Resistant Klebsiella pneumoniae. [PDF]
Mutha M, Subramani P, A R.
europepmc +1 more source
Efficacy and safety of ceftazidime-avibactam in carbapenem-resistant gram-negative bacilli sepsis according to infection site. [PDF]
Ru S, Ji F, Yang G, Xv H.
europepmc +1 more source

